Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2024, titled "Alembic Pharmaceuticals receives one US Food & Drug Administration (USFDA) product approval (Tentative) during the quarter ended 31st March, 2024.".